MétaCan
Menu
Back to cohort
Record W7154856640 · doi:10.4103/sjmr.sjmr_3_25

The Impact of Hydroxocobalamin on Vasodilatory Shock: A Systematic Review and Meta-analysis Study

2025· article· en· W7154856640 on OpenAlexaboutno aff
Samiah Alsohimi, Mohamed Mohamed Belal, Mashael AlFaifi, Ohoud Aljuhani, Alaa Almagthali, Asma A. Alshehri, Alanood Alanazi, Mashael S. Alaboud, Bassam Mohammed Alanazi, Renad Alshuraim, Mohamed A. Albekery, Khalid Al Sulaiman

Bibliographic record

VenueThe SCAPE Journal for Multidisciplinary Research and Development · 2025
Typearticle
Languageen
FieldMedicine
TopicAcute Kidney Injury Research
Canadian institutionsnot available
Fundersnot available
KeywordsHydroxocobalaminVasodilationIntensive care unitRandomized controlled trialObservational studyIntensive careClinical trial

Abstract

fetched live from OpenAlex

Background: Vasodilatory shock, defined as systemic vasodilation and impaired tissue perfusion, is a critical condition associated with high morbidity and mortality in critically ill patients. Current treatments often include norepinephrine as the first-line vasopressor, but there is limited guidance on secondary agents for refractory vasodilatory shock. Hydroxocobalamin (HCB), a Vitamin B12 derivative, has emerged as a potential therapy due to its nitric oxide binding and antioxidant properties. This systematic review and meta-analysis evaluated the impact of HCB on vasodilatory shock in critically ill patients. Methods: A systematic search was conducted across a comprehensive literature search through PubMed, Web of Science, Scopus, and Cochrane. Eligible studies included randomized controlled trials (RCTs) and observational studies comparing HCB pre–postadministration, placebo, and methylene blue. The primary outcomes were vasopressor requirements and mean arterial pressure (MAP), while the secondary outcomes included systemic vascular resistance (SVR), intensive care unit (ICU), hospital length of stay (LOS), mortality, and renal replacement therapy (RRT). The meta-analysis assessed the quality using the Newcastle-Ottawa scale and the ROB2 tool. Results: Of 1793 studies screened, eight studies (one RCT and seven observational) with 467 patients were included. HCB significantly reduced vasopressor requirements within 30–60 min of postadministration (mean difference [MD]: −0.07 mcg/kg/min, 95% confidence interval [CI]: −0.11 to − 0.03) and increased MAP (MD: 7.91 mmHg, 95% CI: 5.36 to 10.47) compared to preadministration. However, no significant differences were observed in hospital or ICU LOS, mortality, MAP after 24 h, SVR, or the need for RRT. Conclusion: HCB demonstrates a reduction in vasopressor requirements and a transient increase in MAP in vasodilatory shock. However, it does not have a statistically significant impact on longer-term outcomes such as ICU LOS or mortality. Further high-quality studies and RCTs are needed to confirm the HCB impact on vasodilatory shock.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.012
metaresearch head score (Gemma)0.026
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Meta-analysis · Consensus signal: Meta-analysis
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.019
Threshold uncertainty score0.064

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0120.026
Meta-epidemiology (narrow)0.0030.001
Meta-epidemiology (broad)0.0190.042
Bibliometrics0.0060.008
Science and technology studies0.0010.001
Scholarly communication0.0030.002
Open science0.0020.002
Research integrity0.0020.002
Insufficient payload (model declined to judge)0.0040.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.164
GPT teacher head0.502
Teacher spread0.339 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designMeta-analysis
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueThe SCAPE Journal for Multidisciplinary Research and DevelopmentSame topicAcute Kidney Injury ResearchFrench-language works237,207